Kidney Transplantation Compatibility Assessment
HLA Matching Analysis
- The donor and recipient share matching at HLA-B44, DR4, DR13, DR53, and DR52 loci, which suggests a favorable outcome with lower risk of rejection and graft failure 1, 2
- These shared antigens represent significant compatibility, particularly at the critical DR loci which are strongly associated with transplant outcomes 1, 3
- Mismatches exist at HLA-A loci and one B locus, but HLA class I mismatches generally have less impact on long-term outcomes than HLA class II mismatches 1
Clinical Significance of This Match
- The matching at both DR4 and DR13 loci is particularly important, as HLA-DR matching is considered a priority in kidney transplantation 1, 2
- The matching at DR52 and DR53 further enhances compatibility 4
- B44 matching provides additional compatibility benefit 1, 2
- The presence of multiple HLA-DR matches significantly reduces the risk of rejection episodes and improves long-term graft survival 1
- The shared DR antigens reduce the risk of developing donor-specific antibodies post-transplantation 3
Crossmatching Considerations
- Despite good HLA matching, a crossmatch test is mandatory before proceeding with transplantation 1, 2
- Both flow cytometry and complement-dependent cytotoxicity (CDC) assays should be performed to rule out preformed antibodies 2
- A positive crossmatch with IgG antibodies to HLA antigens would be a contraindication to transplantation, regardless of HLA matching 2
- A negative flow cytometry or anti-human globulin (AHG)-CDC crossmatch would indicate green light for transplantation 2
- IgM antibody positivity alone is not a contraindication to transplantation 2
ABO Compatibility
- ABO blood group compatibility must be established before proceeding with transplantation, as this is the first step in determining donor-recipient compatibility 5
- ABO compatibility testing should be performed twice to minimize errors 5